Search results for: Policy Analysis
Filter search results
An Insurance Framework for Funding New Antibiotics
22 September 2017
…on a Policy of Risk Mitigation” has been published online in Health Policy OHE Director Adrian Towse and OHE Visiting Fellow Jorge Mestre-Ferrandiz are co-authors along with Chris Hoyle, Jonathan…
Alan Maynard – Alas No More
5 February 2018
…up a little yellow paperback book called Maynard Matters – Critical Thinking on Health Policy which will tell you nearly all you need to know about him and why he…
Making Outcome-based Payments a Reality in the NHS: A Research Collaboration between OHE, RAND Europe and King’s College London
15 May 2018
…reimbursement) and cancer patient-reported outcomes (e.g using quality-adjusted life years, comparing generic versus condition-specific measures and discrete choice experiments) Patricia Cubi-Mollá, experienced in the analysis of adaptation to chronic illnesses,…
New OHE Research Funding: Improving Labour Productivity in Primary Care
17 December 2019
…production function, and the scope of using better triage alongside skill mix improvements. This analysis will employ data from the RCGP’s RSC, a high-quality dataset of routinely collected patient and…
The Broader Value of Existing Vaccines in the Fight Against COVID-19: Beware of Tunnel Vision
8 October 2020
…governments to counter the downturn with fiscal and monetary policy support (World Bank, 2020). A vaccine that would effectively prevent this disease will, therefore, have a broad value to society…
Cost-Effectiveness Thresholds and Expert Elicitation: a Bridge Too Far?
29 April 2021
…technologies (e.g. drugs and medical devices) in many health systems is informed by cost-effectiveness analysis, comparing the incremental gains from a new technology against best alternative uses of that money….
OHE Thanks Trustees for Their Service
17 December 2021
…Donabedian Award in recognition of lifetime achievement in the area of improving health outcomes. Mike Drummond took over from Professor Tony Culyer as Chair of the OHE Policy Committee in…
The R&D Cost of a New Medicine
1 December 2012
The cost of R&D for a successful new medicine has been an important policy issue at least since the 1960s. Cost estimates matter not just because of intellectual curiosity or…
Medicines, Health and the Poor World
1 April 1982
…agencies took up new stances in relation to health care in the ‘poor world’. For instance, in 1975 the World Bank produced the first of its health sector policy papers….